Long-Term Outcomes of Stent-Less Strategy Using Directional Coronary Atherectomy for the Ostial Left Circumflex

Hidenari Matsumura1, Kenichiro Shimoji1

  • 1Department of Cardiology, Saiseikai Utsunomiya Hospital, Utsunomiya, Japan.

Insights

A stent-less approach using directional coronary atherectomy (DCA) and drug-eluting balloon (DEB) shows promising long-term results for left circumflex artery ostial lesions. This percutaneous coronary intervention (PCI) strategy offers a viable alternative to traditional stenting.

Area of Science:

  • Interventional Cardiology
  • Vascular Medicine
  • Cardiovascular Interventions

Background:

  • Long-term outcomes of percutaneous coronary intervention (PCI) for left circumflex artery (LCX) ostial lesions are suboptimal.
  • Stent-less strategies using directional coronary atherectomy (DCA) and drug-eluting balloons (DEB) are being explored as alternatives.
  • Limited data exists on the long-term efficacy of DCA and DEB for LCX ostial lesions.

Purpose of the Study:

  • To evaluate the long-term outcomes of a stent-less PCI strategy.
  • To assess the use of DCA followed by DEB for treating LCX ostial lesions.
  • To compare this approach with conventional stent-based PCI strategies.

Main Methods:

  • Retrospective analysis of patients treated with DCA and DEB for LCX ostial lesions (January 2019 - January 2024).
  • DCA was used to reduce plaque area to <60%, followed by DEB angioplasty.
  • Primary endpoint: clinically driven target lesion revascularization (TLR). Secondary endpoints: major adverse cardiac events (MACE) and bleeding complications.

Main Results:

  • Ten patients were included; 50% had diabetes mellitus.
  • 80% had concomitant left main trunk (LMT) to left anterior descending artery (LAD) lesions.
  • One patient (10%) experienced TLR; no cardiac death, myocardial infarction (MI), or bleeding complications were observed. Median follow-up was 22 months.

Conclusions:

  • Directional coronary atherectomy (DCA) followed by drug-eluting balloon (DEB) angioplasty demonstrates favorable long-term outcomes for LCX ostial lesions.
  • This stent-less PCI approach offers a viable alternative to conventional stent-based strategies.
  • Further research is warranted to confirm these findings in larger cohorts.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
450
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
747
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
659